(1)
Mayo, T.; Armstrong, A. W.; Kircik, L.; Silverberg, J. I.; Blauvelt, A.; Esdalie, B.; Schneider, S.; Mark, T.; Gooderham, M.; Alexis, A. F. Efficacy and Safety of Tralokinumab Treatment in Adults of Different Racial Subgroups With Moderate-to-Severe Atopic Dermatitis in Three Randomized, Placebo-Controlled Phase 3 Trials. J of Skin 2022, 6, s76.